These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21479354)

  • 1. Cannabinoids and innate immunity: taking a toll on neuroinflammation.
    Downer EJ
    ScientificWorldJournal; 2011 Apr; 11():855-65. PubMed ID: 21479354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor signalling as a cannabinoid target.
    Cui Sun M; Otálora-Alcaraz A; Prenderville JA; Downer EJ
    Biochem Pharmacol; 2024 Apr; 222():116082. PubMed ID: 38438052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
    Li L; Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2021 Jan; 91():740-755. PubMed ID: 33039660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
    McCoy KL
    Mediators Inflamm; 2016; 2016():5831315. PubMed ID: 27597805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.
    Squillace S; Salvemini D
    Trends Pharmacol Sci; 2022 Sep; 43(9):726-739. PubMed ID: 35753845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors.
    Guo LH; Schluesener HJ
    Cell Mol Life Sci; 2007 May; 64(9):1128-36. PubMed ID: 17440679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
    Correa F; Mestre L; Molina-Holgado E; Arévalo-Martín A; Docagne F; Romero E; Molina-Holgado F; Borrell J; Guaza C
    Mini Rev Med Chem; 2005 Jul; 5(7):671-5. PubMed ID: 16026313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.
    Cabral GA; Griffin-Thomas L
    Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):159-72. PubMed ID: 18782012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
    Chiurchiù V; Leuti A; Maccarrone M
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):268-80. PubMed ID: 25601726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical/Therapeutic Approaches for Cannabinoid Ligands in Central and Peripheral Nervous System Diseases: Mini Review.
    Fijał K; Filip M
    Clin Neuropharmacol; 2016; 39(2):94-101. PubMed ID: 26818043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
    Carty M; Bowie AG
    Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
    Fitzpatrick JK; Downer EJ
    Neuropharmacology; 2017 Feb; 113(Pt B):618-626. PubMed ID: 27079840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors are key participants in innate immune responses.
    Arancibia SA; Beltrán CJ; Aguirre IM; Silva P; Peralta AL; Malinarich F; Hermoso MA
    Biol Res; 2007; 40(2):97-112. PubMed ID: 18064347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like receptors (TLRs) and their ligands.
    Uematsu S; Akira S
    Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
    Croxford JL; Yamamura T
    J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases.
    Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2022 May; 102():163-178. PubMed ID: 35176442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors in kidney disease.
    Smith KD
    Curr Opin Nephrol Hypertens; 2009 May; 18(3):189-96. PubMed ID: 19352178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.